Compassionate Use of Sodium Stibogluconate (Pentostam) for Cutaneous and Mucocutaneous New World Leishmaniasis

• Status: Available
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

Patients with biopsy proven new world cutaneous or mucocutaneous leishmaniasis will be treated with sodium stibogluconate (Pentostam).

Details

• Lead Sponsor: University of California, San Francisco
• Treatments: Antimony Sodium Gluconate

Criteria

Inclusion Criteria:

• Biopsy proven new world cutaneous or mucocutaneous leishmania

Exclusion Criteria:

• Prolonged QT

• Liver disease

• Pancreatitis